US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

36.57

-0.2300-0.62%

Post-market: 36.570.00000.00%19:30 EDT

Volume:21.69K

Turnover:793.57K

Market Cap:95.45M

PE:- -

High:36.78

Open:36.78

Low:36.42

Close:36.80

52wk High:36.84

52wk Low:23.32

Shares:2.61M

Float Shares:2.61M

Volume Ratio:0.26

T/O Rate:0.83%

Dividend:0.26

Dividend Rate:0.70%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC

Gilead - EU Grants Marketing Authorization for Trodelvy with Keytruda in First-Line Pd-L1-Positive Metastatic Tnbc

THOMSON REUTERS

European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status

THOMSON REUTERS

BAO PHARMA-B (02659) Receives US FDA Clearance for KJ015 Injection Clinical Trial Application

Drug Innovation and Computing Hardware Supply Chains Plunge, ChiNext Index Falls Over 3% | 3A Daily Report (August 24, 2026)

Hong Kong Biotech ETF Offers Full-Chain Access as Drug Developers and CXO Partners Enter Harvest Season

Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027

Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?

Simply Wall St.

Regeneron Pharmaceuticals (REGN) Wins Pasatru Approval, Is The Upside Already Priced In?

Simply Wall St.

Funds: What a Top Biotech Fund is Buying Now

Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60

Moderna Inc. Stock Advances 8.9%, Outperforms Peers

Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit

Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study

Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims

SBP Group's Novel Weight Management Therapy Gains Regulatory Nod for Clinical Trials

Biokin's RMB1.78 Billion Milestone Revenue Recognition Raises Red Flags as BMS Payment Remains Outstanding

Apichope's Subsidiary Gains Regulatory Nod for Novel Drug Trial Application

When This Sector Rallies, Tech Takes a Backseat

Gilead (GILD) Stock Still Looks Below Fair Value As Court Backs HIV Import Block

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/IBBQ/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":36.57,"timestamp":1787774400000,"preClose":36.8,"halted":0,"volume":21693,"hourTrading":{"tag":"盘后","latestPrice":36.57,"preClose":36.57,"latestTime":"19:30 EDT","volume":138,"amount":5035.788,"timestamp":1787787003652,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.006249999999999915,"floatShares":2610001,"shares":2610001,"eps":0,"marketStatus":"Not Yet Opened","change":-0.23,"latestTime":"08-26 16:00:00 EDT","open":36.78,"high":36.78,"low":36.42,"amount":793570.4408310001,"amplitude":0.009783,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787817600000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":36.8,"sharesOutstanding":2520001,"nav":36.70729,"aum":95806063.60729,"dividendRate":0.007044,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":36.76,"preClose":36.8,"latestTime":"09:29 EDT","volume":101,"amount":3712.795653,"timestamp":1787750998097,"change":-0.04,"changeRate":-0.001087,"amplitude":0.00097},"postHourTrading":{"tag":"盘后","latestPrice":36.57,"preClose":36.57,"latestTime":"19:30 EDT","volume":138,"amount":5035.788,"timestamp":1787787003652,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.260535,"impliedVol":0.0839,"impliedVolPercentile":0.3466},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2610001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.260535,"shares":2610001,"dividePrice":0.2576,"high":36.78,"amplitude":0.009783,"preClose":36.8,"low":36.42,"week52Low":23.315,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":36.57,"eps":0,"divideRate":0.007044,"volume":21693,"delay":0,"ttmEps":0,"open":36.78,"prevYearClose":28.3962,"prevWeekClose":36.29,"prevMonthClose":32.1008,"prevQuarterClose":32.66,"fiveDayClose":36.8205,"twentyDayClose":32.41,"sixtyDayClose":29.2526},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"IBBQ","amount":0.0287,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661278374","title":"EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2661278374","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661278374?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567503,"startTime":"0","endTime":"0","summary":"EU Commission approves Gilead Trodelvy-Keytruda combo for first-line PD-L1+ metastatic TNBCEuropean Commission granted marketing authorization for Trodelvy with Merck’s Keytruda in first-line metastat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL4gZS8y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","BK4583","LU0965509101.SGD","LU1571399168.USD","SG9999015978.USD","LU1430594728.SGD","IE00B3T34201.USD","SG9999015952.SGD","LU1674673691.USD","LU0114720955.EUR","BIB","IBBQ","LU1934455194.USD","BBH","SG9999015986.USD","LU2468319806.SGD","LU0882574055.USD","LU1934455863.HKD","IE0002270589.USD","LU1037948897.HKD","BK4566","LU2357627491.SGD","LU1037948541.HKD","LU0320765992.SGD","LU2089984988.USD","LU0058720904.USD","LU1061106388.HKD","LU1585245621.USD","LU1778281490.HKD","LU0965509283.SGD","LU0109394709.USD","LU1934455277.USD","IE00B19Z3581.USD","LU1023059063.AUD","BK4550","LU0965508806.USD","IE00BZ1G4Q59.USD","MEDI","LU0289739699.SGD","TBXU","LU1066051498.USD","BK4585","IBB","BMED","LU0861579265.USD","LU1057294990.SGD","LU0859254822.USD","LU0965509010.AUD","TMED","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661325278","title":"Gilead - EU Grants Marketing Authorization for Trodelvy with Keytruda in First-Line Pd-L1-Positive Metastatic Tnbc","url":"https://stock-news.laohu8.com/highlight/detail?id=2661325278","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661325278?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUAMP4X3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1674673691.USD","GILD","BK4139","BK4588","LU1934455194.USD","BK4566","LU1934455277.USD","LU1934455863.HKD","TMED","LU1585245621.USD","LU2324357040.USD","LU1674673428.USD","LU1061106388.HKD","SG9999015945.SGD","IE00B7SZLL34.SGD","SG9999015978.USD","BK4550","IE00BSNM7G36.USD","LU1066053197.SGD","LU2468319806.SGD","IE0002270589.USD","LU1066051498.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","SG9999015986.USD","IBBQ","LU0289739699.SGD","LU1057294990.SGD","MEDI","LU0234570918.USD","TBXU","LU0965508806.USD","IE00B3T34201.USD","BK4568","LU0965509283.SGD","BK4585","LU0965509010.AUD","LU1037948897.HKD","IBB","BMED","LU2357627491.SGD","IE00B19Z3B42.SGD","LU1839511570.USD","LU0889565916.HKD","LU0058720904.USD","LU0965509101.SGD","SG9999015952.SGD","BBH","LU1023059063.AUD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661278323","title":"European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status","url":"https://stock-news.laohu8.com/highlight/detail?id=2661278323","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661278323?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUAMP4X3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BMED","LU1585245621.USD","LU2357627491.SGD","LU0289739699.SGD","BK4566","LU1037948897.HKD","LU0114720955.EUR","LU0320765992.SGD","LU2087621335.USD","LU0109394709.USD","IBB","LU0234570918.USD","BK4585","LU0859254822.USD","TBXU","LU1037948541.HKD","LU0823416689.USD","BK4139","SG9999015978.USD","LU2324357040.USD","LU1061106388.HKD","LU1674673691.USD","GILD","BK4588","SG9999015945.SGD","BK4532","LU0058720904.USD","SG9999015952.SGD","BK4568","IE00B19Z3581.USD","SG9999015986.USD","IE00B7SZLL34.SGD","LU1934455863.HKD","BBH","LU0861579265.USD","LU0882574055.USD","IE00BKVL7J92.USD","LU1674673428.USD","LU2089984988.USD","LU0889565916.HKD","BIB","MEDI","BK4583","IE00B19Z3B42.SGD","IBBQ","LU1057294990.SGD","LU1066053197.SGD","LU0122379950.USD","TMED","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181313648","title":"BAO PHARMA-B (02659) Receives US FDA Clearance for KJ015 Injection Clinical Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1181313648","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181313648?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:08","pubTimestamp":1787566138,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) has announced that on August 21, 2026, its independently developed KJ015 injection, a subcutaneous formulation of a bispecific antibody targeting HER2, received Investigational...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IBBQ","IBBJ","02659","PSYK","BMED","MDTX","BK1161","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149972463","title":"Drug Innovation and Computing Hardware Supply Chains Plunge, ChiNext Index Falls Over 3% | 3A Daily Report (August 24, 2026)","url":"https://stock-news.laohu8.com/highlight/detail?id=1149972463","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149972463?lang=en_us&edition=fundamental","pubTime":"2026-08-24 17:50","pubTimestamp":1787565027,"startTime":"0","endTime":"0","summary":"The ChiNext Index dropped more than 3% on Tuesday as steep declines in innovative drug development and computing hardware supply chain stocks weighed heavily on market sentiment. 永泰生物-B...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399006","MEDX","399001","159992","IBBQ","03147","BK1574","07234","06978","LNGR","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184884128","title":"Hong Kong Biotech ETF Offers Full-Chain Access as Drug Developers and CXO Partners Enter Harvest Season","url":"https://stock-news.laohu8.com/highlight/detail?id=1184884128","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184884128?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:10","pubTimestamp":1787559055,"startTime":"0","endTime":"0","summary":"China's innovative drug industry chain is entering a phase where earnings and international expansion are materializing. According to recent interim reports and earnings previews from listed...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","WX","159992","IBBQ","BK1574","520970","06978","LNGR","CXO","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661222504","title":"Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2661222504","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661222504?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:00","pubTimestamp":1787554851,"startTime":"0","endTime":"0","summary":"Daiichi Sankyo names Ken Keller chief commercialization officer, effective April 2027Daiichi Sankyo named Ken Keller chief commercialization officer, effective April 1, 2027, to run a new globally int","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDLbyMxfX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","IBBQ","LU1023059063.AUD","LU0320765992.SGD","BK4533","BK4566","IE0002141913.USD","TBXU","IE00BJJMRZ35.SGD","LU0889565916.HKD","LU2242652126.USD","LU2468319806.SGD","LU1571399168.USD","LU2242646821.SGD","BK4534","BIB","BK4599","LU1061106388.HKD","PBE","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4588","IE00B4R5TH58.HKD","BK4585","LU2089984988.USD","LU1057294990.SGD","LU0289739699.SGD","IE00BJT1NW94.SGD","LU0058720904.USD","LU2112291526.USD","LU0122379950.USD","LU1983299246.USD","SG9999001440.SGD","AMGN","IBB","BK4139","LU0868494617.USD","LU0109394709.USD","PJP","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661228075","title":"Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661228075","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661228075?lang=en_us&edition=fundamental","pubTime":"2026-08-24 11:29","pubTimestamp":1787542174,"startTime":"0","endTime":"0","summary":"Earlier in August 2026, VIAVI Solutions launched Vertex 6.0, an enhanced channel emulation platform with 400 MHz instantaneous bandwidth and support for carrier frequencies up to 23.6 GHz, targeting next-generation 6G and Wi‑Fi 7/8 testing and integrating real-world RF propagation into lab environments.\nThis upgrade, the first since acquiring Spirent’s high-speed Ethernet, network security and channel emulation testing business, positions Vertex 6.0 as a modular RF digital twin platform...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/is-viavi-solutions-viav-quietly-recasting-its-6g-moat-with-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/is-viavi-solutions-viav-quietly-recasting-its-6g-moat-with-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2417539215.USD","LU0889565916.HKD","LU1093756325.SGD","LU1559883803.SGD","LU2089984988.USD","IE00B4R5TH58.HKD","LU1069344957.HKD","IE0002141913.USD","LU2236285917.USD","LU2065170008.USD","BK4588","TBXU","VIAG","BK4567","PBE","BIB","LU0109394709.USD","VERX","BK4585","QTOC","BK4023","AIPO","SG9999001176.SGD","IDNA","IBB","IBBQ","VRTX","LU0205194284.USD","IE00B2B36J28.USD","CHAT","LU2362540622.SGD","LU1674673428.USD","ARTY","LU0240877869.USD","LU1585245621.USD","LU2065171402.SGD","VTHR","BBH","VIAV","BK4532","LU0061475181.USD","AGIX","LU0417517546.SGD","IE00B19Z9Z06.USD","LU2065171311.SGD","LU0234570918.USD","LU0432979614.USD","SG9999013999.USD","GNMX","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661302215","title":"Regeneron Pharmaceuticals (REGN) Wins Pasatru Approval, Is The Upside Already Priced In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661302215","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661302215?lang=en_us&edition=fundamental","pubTime":"2026-08-22 09:30","pubTimestamp":1787362233,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (REGN) stock moved after the U.S. Food and Drug Administration approved Pasatru for adults with fibrodysplasia ossificans progressiva. This new rare disease therapy is supported by late stage OPTIMA trial data.\nSee our latest analysis for Regeneron Pharmaceuticals.\nThe Pasatru approval comes after a strong run in Regeneron Pharmaceuticals’ stock, with a 30.55% 90 day share price return and a 42.21% 1 year total shareholder return, suggesting recent momentum after...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/regeneron-pharmaceuticals-regn-wins-pasatru-approval-is-the","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/regeneron-pharmaceuticals-regn-wins-pasatru-approval-is-the","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0289739699.SGD","LU2468319806.SGD","LU0114720955.EUR","LU0823434583.USD","LU0320765992.SGD","LU0109394709.USD","LU2362541273.HKD","IBB","DCF","BK4585","LU2362540622.SGD","TBXU","LU0823434740.USD","LU0823416689.USD","BK4139","REGN","BK4588","LU0058720904.USD","LU2362541513.USD","LU1974910355.USD","LU2023250504.SGD","BBH","LU0882574055.USD","LU0053666078.USD","LU2106854487.HKD","LU2089984988.USD","LU0889565916.HKD","IBBQ","LU1917777945.USD","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661213210","title":"Funds: What a Top Biotech Fund is Buying Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2661213210","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661213210?lang=en_us&edition=fundamental","pubTime":"2026-08-22 09:30","pubTimestamp":1787362200,"startTime":"0","endTime":"0","summary":"It's hard to find a more experienced biotech investor than Evan McCulloch. The manager of Franklin Biotechnology Discovery has been running the $1.2 billion fund since 1997.That matters in this highly","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRTX","LU1674673428.USD","IBB","BK4534","IE00BFTCPJ56.SGD","BK4588","LU2468319806.SGD","LU2462157665.USD","IE00BKVL7J92.USD","BIB","LU1093756168.USD","IE00B19Z9Z06.USD","BK4599","IE00B894F039.SGD","SG9999013999.USD","LU0079474960.USD","LU2362541273.HKD","LU1093756325.SGD","04332","LU2456880835.USD","IE00B19Z3B42.SGD","LU2242652126.USD","LU2237438978.USD","LU2242646821.SGD","LU2362540622.SGD","BK4567","BK4583","LU2236285917.USD","LU0053666078.USD","IE00BN0W2W23.USD","LU0965509010.AUD","PBE","GNMX","LU0965509101.SGD","LU2089984988.USD","LU1069344957.HKD","IE00BZ9MQY76.HKD","LU1066051498.USD","IE00BJJMRZ35.SGD","LU2112291526.USD","LU0889565916.HKD","LU1974910355.USD","IE00BJT1NW94.SGD","LU0965508806.USD","IE00BZ1G4Q59.USD","LU1057294990.SGD","PJP","SG9999001440.SGD","SG9999015952.SGD","LU2417539215.USD","TMED","LU0109394709.USD","LU1839511570.USD","LU0256863811.USD","IE00B7SZLL34.SGD","LU0882574055.USD","LU1061106388.HKD","REGN","LU0320765992.SGD","MEDI","IE00BN0W2V16.EUR","LU1778281490.HKD","LU1585245621.USD","BMED","LU2087621335.USD","LU0114720955.EUR","LU0868494617.USD","LU2324357040.USD","IE00B19Z9P08.USD","LU0122379950.USD","BK4533","SG9999015978.USD","LU0823434583.USD","IE00BN0W2T93.GBP","BK4550","LU0823416689.USD","IE0009355771.USD","LU1934455194.USD","BK4568","LU1917777945.USD","LU0289739699.SGD","LU0861579265.USD","LU0154245756.USD","LU2106854487.HKD","BK4007","LU0859254822.USD","IE00B19Z3581.USD","SGXZ57979304.SGD","IE00B3T34201.USD","SG9999001176.SGD","IE0002270589.USD","LU0058720904.USD","BK4581","LU0965509283.SGD","LU2023250504.SGD","SG9999001176.USD","LU0154245673.USD","IE0002141913.USD","LU0417517546.SGD","BK4139","LU1571399168.USD","IE00BSNM7G36.USD","BK4532","LU1066053197.SGD","LU2357627491.SGD","BBH","SG9999015986.USD","LU0061475181.USD","LU0234570918.USD","LU1037948897.HKD","LU1430594728.SGD","IE00B4R5TH58.HKD","LU0432979614.USD","JAZZ","LU1037948541.HKD","BK4566","LU1934455277.USD","BK4578","IE00B2B36J28.USD","IBBQ","GILD","LU1023059063.AUD","LU2362541513.USD","BK4585","LU1035775433.USD","LU1674673691.USD","AMGN","SG9999015945.SGD","TBXU","XBI","LU1983299246.USD","IDNA","LU1934455863.HKD","LU0823434740.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661187372","title":"Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60","url":"https://stock-news.laohu8.com/highlight/detail?id=2661187372","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661187372?lang=en_us&edition=fundamental","pubTime":"2026-08-22 07:22","pubTimestamp":1787354576,"startTime":"0","endTime":"0","summary":"Gilead director Jeffrey Bluestone disposes of 5,000 common shares worth $727,333.60Gilead director Jeffrey Bluestone exercised stock options on Aug. 20, 2026, acquiring 5,000 shares at USD 61.35 to US","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL4cgVd7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1778281490.HKD","LU2468319806.SGD","SG9999015945.SGD","LU0965509283.SGD","LU2089984988.USD","TMED","LU1066053197.SGD","LU0320765992.SGD","BK4588","IBB","IE00B19Z3B42.SGD","TBXU","IE00B7SZLL34.SGD","LU0882574055.USD","BK4532","LU0965508806.USD","LU2357627491.SGD","LU1430594728.SGD","LU1674673691.USD","LU1934455863.HKD","LU0058720904.USD","IBBQ","BK4568","SG9999015986.USD","LU0861579265.USD","IE00B3T34201.USD","GILD","LU1571399168.USD","LU1674673428.USD","IE00BSNM7G36.USD","LU0965509010.AUD","SG9999015978.USD","LU2087621335.USD","BMED","LU0289739699.SGD","BIB","LU1023059063.AUD","LU0234570918.USD","BK4139","LU1057294990.SGD","LU1585245621.USD","LU0965509101.SGD","MEDI","SG9999015952.SGD","IE00B19Z3581.USD","BBH","LU0859254822.USD","LU0122379950.USD","BK4566","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661972042","title":"Moderna Inc. Stock Advances 8.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2661972042","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661972042?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:33","pubTimestamp":1787344380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rose 8.9% to $145.13 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.4% to 26,180.45 and the Dow Jones Industrial Average rising 1.0% to 53,277.01.Moderna Inc. closed 17.8% below its 52-week high of $176.66, which the company reached on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.24, Pfizer Inc. rose 1.0% to $28.07, and Gilead Sciences Inc. rose 1.87% to $146.12.Trading volume totaled 86.7 million, compared to the 50-day average of 13.0 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","TBXU","MRNY","BBH","GILD","BK4532","LU0965509283.SGD","IBBQ","LU1061106388.HKD","LU0122379950.USD","LU0320765992.SGD","WDNA","LGHT","LU1430594728.SGD","LU0234570918.USD","BK4501","IDNA","GNOM","LU2357627491.SGD","IBB","LU1066053197.SGD","LU0823416689.USD","SG9999015978.USD","BK4585","LU1057294990.SGD","LU2112291526.USD","LU1934455194.USD","LU1037948541.HKD","SG9999015986.USD","BK4583","LU1839511570.USD","LU2324357040.USD","LU0289739699.SGD","MRNA","BK4550","BIB","LU1585245621.USD","LU1934455863.HKD","BK4551","LU0965508806.USD","LU1571399168.USD","LU0058720904.USD","MRNX","BMED","IE0002270589.USD","LU0965509010.AUD","SG9999015952.SGD","LU1674673691.USD","TMED","LU0861579265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661940352","title":"Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2661940352","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661940352?lang=en_us&edition=fundamental","pubTime":"2026-08-22 01:58","pubTimestamp":1787335117,"startTime":"0","endTime":"0","summary":"Gilead declares Q3 2026 dividend of R$ 0.24 per unitGilead Sciences set a Q3 2026 distribution of R$ 0.24 per unit for BRGILDBDR 000.Last day to trade with rights: Sept. 11, 2026.Payment date: Oct. 5,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL12Yy9R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","LU0859254822.USD","LU0823416689.USD","GILD","BIB","IE00BSNM7G36.USD","LU1037948541.HKD","BK4583","LU1674673428.USD","IE00B19Z3B42.SGD","BK4585","IBBQ","MEDI","BK4588","LU0320765992.SGD","LU0965508806.USD","IE0002270589.USD","LU0882574055.USD","LU1066053197.SGD","LU0965509101.SGD","LU2112291526.USD","LU1430594728.SGD","LU0889565916.HKD","IE00B3T34201.USD","SG9999015952.SGD","LU2324357040.USD","LU2357627491.SGD","LU2089984988.USD","LU0965509010.AUD","BK4139","LU1674673691.USD","IE00BKVL7J92.USD","BK4568","BK4532","LU2468319806.SGD","LU1037948897.HKD","BK4550","LU1585245621.USD","BBH","LU0965509283.SGD","IBB","LU0122379950.USD","BMED","BK4578","TMED","TBXU","LU1061106388.HKD","LU0114720955.EUR","SG9999015986.USD","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661887294","title":"Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2661887294","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661887294?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:34","pubTimestamp":1787330049,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s new Phase 3 DeLLphi-315 study tests its cancer drug tarlatamab in pe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-advances-tarlatamab-shot-vs-infusion-in-phase-3-lung-cancer-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-advances-tarlatamab-shot-vs-infusion-in-phase-3-lung-cancer-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2242646821.SGD","LU0320765992.SGD","LU2468319806.SGD","BK4566","LU0289739699.SGD","IBBQ","BK4581","BK4533","PBE","BK4599","IE0002141913.USD","IE0009355771.USD","TBXU","LU1571399168.USD","LU0122379950.USD","LU0109394709.USD","SG9999001440.SGD","LU1061106388.HKD","LU0889565916.HKD","IE00B4R5TH58.HKD","AMGN","BK4585","LU2089984988.USD","BK4534","BK4139","LU1057294990.SGD","BIB","PJP","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU1983299246.USD","LU2242652126.USD","BBH","LU1023059063.AUD","BK4588","IBB","IE00B2B36J28.USD","LU0058720904.USD","LU2112291526.USD","IE00BJT1NW94.SGD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260437","title":"Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260437","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260437?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:58","pubTimestamp":1787313533,"startTime":"0","endTime":"0","summary":"A class action lawsuit was filed against biotechnology company Regeneron ($REGN) on July 16, which could put further pressure on its troubled share...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/regeneron-stock-regn-buckling-as-shareholders-sue-over-cancer-drug-claims?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/regeneron-stock-regn-buckling-as-shareholders-sue-over-cancer-drug-claims?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU1974910355.USD","DARP","JDOC","LU0058720904.USD","LU0053666078.USD","XT","IBBQ","LU0882574055.USD","AGNG","LU2468319806.SGD","LU1917777945.USD","BK4585","SYNB","RSPH","BK4588","BBP","LU0289739699.SGD","LU0823434583.USD","LU0889565916.HKD","LU2106854487.HKD","LU2362540622.SGD","REGN","LU0823416689.USD","LU2362541513.USD","LU2089984988.USD","LU0114720955.EUR","LNGR","FWD","TBXU","BBH","LU2237438978.USD","BK4139","IBB","LU2362541273.HKD","LU0823434740.USD","FHLC","IEIH","LU2023250504.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163803683","title":"SBP Group's Novel Weight Management Therapy Gains Regulatory Nod for Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1163803683","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163803683?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:38","pubTimestamp":1787308697,"startTime":"0","endTime":"0","summary":"SBP GROUP (01177) has announced that its subsidiary, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., has received approval from the Center for Drug Evaluation (CDE) of China's National Medical...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","01177","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","IBBQ","BK1191","BK1521","BK1589","BMED","IE00BZ08YR35.GBP","MDTX","IBBJ","PSYK","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123726115","title":"Biokin's RMB1.78 Billion Milestone Revenue Recognition Raises Red Flags as BMS Payment Remains Outstanding","url":"https://stock-news.laohu8.com/highlight/detail?id=1123726115","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123726115?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:31","pubTimestamp":1787297518,"startTime":"0","endTime":"0","summary":"Sichuan Biokin Pharmaceutical Co., Ltd. (688506) has found itself at the center of a financial reporting controversy, with its 2025 annual results showing a staggering RMB1.78 billion milestone...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMS","BK0239","688506","IBBQ","91194","MDTX","PSYK","BMED","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158851231","title":"Apichope's Subsidiary Gains Regulatory Nod for Novel Drug Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1158851231","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158851231?lang=en_us&edition=fundamental","pubTime":"2026-08-21 11:52","pubTimestamp":1787284333,"startTime":"0","endTime":"0","summary":"Apichope Pharmaceutical Group Co., Ltd. (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou Yipinhong Pharmaceutical Co., Ltd., has received approval from the National Medical Products...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK1574","IBBJ","159992","MEDX","PSYK","BK0239","BMED","MDTX","BK1161","06978","300723","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165297527","title":"When This Sector Rallies, Tech Takes a Backseat","url":"https://stock-news.laohu8.com/highlight/detail?id=1165297527","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165297527?lang=en_us&edition=fundamental","pubTime":"2026-08-21 09:10","pubTimestamp":1787274639,"startTime":"0","endTime":"0","summary":"On August 19th, the U.S. Treasury Department unexpectedly decided to at least double its long-term bond repurchase program, directly pushing global yields lower. While many assumed tech stocks would...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLD","BK1161","159934","518880","BK1574","MEDX","SGUmain","NUGT","LNGR","06978","IBBQ","SGCmain","GCmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661923014","title":"Gilead (GILD) Stock Still Looks Below Fair Value As Court Backs HIV Import Block","url":"https://stock-news.laohu8.com/highlight/detail?id=2661923014","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661923014?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:35","pubTimestamp":1787258134,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong long term returns over the past five years, yet current valuation checks and market multiples still point to the shares screening as undervalued. With recent news flow focused on its HIV and oncology franchises and on legal protection of its U.S. drug pricing, investors are weighing how much of this is already reflected in the price.\n\nGilead Sciences has returned 148.1% over the past five years, which puts recent valuation questions in the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-still-looks-below-fair-value-as-court-back","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-still-looks-below-fair-value-as-court-back","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BSNM7G36.USD","CDIG","BK4566","LU2468319806.SGD","BK4585","IE0002270589.USD","LU1778281490.HKD","SG9999015986.USD","LU0861579265.USD","TBXU","LU1934455277.USD","LU0823416689.USD","LU0965508806.USD","LU2087621335.USD","GILD","LU1934455194.USD","TMED","BIB","BMED","IE00B19Z3581.USD","LU0889565916.HKD","LU1430594728.SGD","LU1066051498.USD","BBH","SG9999015945.SGD","TACU","IE00BKVL7J92.USD","IBBQ","LU0122379950.USD","LU2089984988.USD","LU1934455863.HKD","IE00B19Z3B42.SGD","BK4588","DAPP","LU0965509283.SGD","LU1037948541.HKD","LU0114720955.EUR","MEDI","LU0289739699.SGD","TSPA","LU0109394709.USD","LU0965509010.AUD","IE00BZ1G4Q59.USD","LU1057294990.SGD","IBB","BK4550","SG9999015978.USD","LU1037948897.HKD","LU2112291526.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}